118 HR 6045 IH: Curbing Illicit Drug Threats Act U.S. House of Representatives 2023-10-25 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

I118th CONGRESS1st SessionH. R. 6045IN THE HOUSE OF REPRESENTATIVESOctober 25, 2023Ms. Caraveo (for herself and Mr. Kean of New Jersey) introduced the following bill; which was referred to the Committee on Energy and CommerceA BILLTo direct the Comptroller General of the United States to conduct a study and submit a report on the efficacy of Federal drug surveillance systems, and for other purposes.

1.

Short title

This Act may be cited as the Curbing Illicit Drug Threats Act.

2.

GAO study and report on efficacy of Federal drug surveillance systems

(a)

Study

The Comptroller General of the United States shall conduct a study on—(1)the efficacy of Federal drug surveillance systems in providing up-to-date information on illicit drug use in the United States, including any limitations affecting such efficacy; and(2)how such systems are used to address illicit drug use in the United States.(b)

Report

Not later than 18 months after the date of enactment of this Act, the Comptroller General of the United States shall complete the study under subsection (a) and submit to Congress a report containing—(1)the findings and conclusions of such study; and(2)any recommendations for legislative or administrative actions to improve the efficacy of the Federal drug surveillance systems examined in such study, including any recommendations pertaining to interagency communication or data collection procedures.(c)

Federal drug surveillance systems defined

In this section, the term Federal drug surveillance systems includes—(1)the Drug Overdose Surveillance and Epidemiology System of the Centers for Disease Control and Prevention (commonly known as DOSE);(2)the State Unintentional Drug Overdose Reporting System of the Centers for Disease Control and Prevention (commonly known as SUDORS);(3)the National Drug Early Warning System of the National Institute on Drug Abuse (commonly known as NDEWS); and(4)the Drug Abuse Warning Network of the Substance Abuse and Mental Health Services Administration (commonly known as DAWN).